MENU
PYPD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
PolyPid (PYPD) Ownership - Who owns PolyPid?
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more
Profile
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
62
Web
https://www.polypid.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
28.02M
P/E Ratio
N/A
Total Cash
15.64M
Projected Growth
N/A
Total Debt
9.62M
Revenue
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash/Share
1.53
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PYPD
Capitalization
28M
P/E Ratio
N/A
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash
15.6M
Total Cash/Share
1.53
Total Debt
9.62M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
7.68M
P/B Ratio
3.65
Cash Flow
N/A
Earnings
-4.91
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
1.31
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-26.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-142.99
Shares Held By Institutions
7.56M
Shares Outstanding - Current
10.2M
Total Liabilities
17.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-9.539
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
62
Web
https://www.polypid.com